Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Dupilumab for Eczema
Recruiting3 awardsPhase 4
Saint Louis, Missouri
This trial is a 2-year study to see how well Dupixent works on improving skin barrier function in children with moderate-to-severe atopic dermatitis (AD). Around 48 children between
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.